Correlation Between UBS ETF and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UBS ETF and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UBS ETF and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UBS ETF MSCI and BB Biotech AG, you can compare the effects of market volatilities on UBS ETF and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UBS ETF with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of UBS ETF and BB Biotech.

Diversification Opportunities for UBS ETF and BB Biotech

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between UBS and BION is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding UBS ETF MSCI and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and UBS ETF is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UBS ETF MSCI are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of UBS ETF i.e., UBS ETF and BB Biotech go up and down completely randomly.

Pair Corralation between UBS ETF and BB Biotech

Assuming the 90 days trading horizon UBS ETF MSCI is expected to generate 0.41 times more return on investment than BB Biotech. However, UBS ETF MSCI is 2.42 times less risky than BB Biotech. It trades about 0.03 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.25 per unit of risk. If you would invest  1,982  in UBS ETF MSCI on September 13, 2024 and sell it today you would earn a total of  6.00  from holding UBS ETF MSCI or generate 0.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

UBS ETF MSCI  vs.  BB Biotech AG

 Performance 
       Timeline  
UBS ETF MSCI 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UBS ETF MSCI has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, UBS ETF is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

UBS ETF and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UBS ETF and BB Biotech

The main advantage of trading using opposite UBS ETF and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UBS ETF position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind UBS ETF MSCI and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Directory
Find actively traded commodities issued by global exchanges